These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8625321)

  • 41. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes.
    Tamura T; Ishihara M; Lamphier MS; Tanaka N; Oishi I; Aizawa S; Matsuyama T; Mak TW; Taki S; Taniguchi T
    Nature; 1995 Aug; 376(6541):596-9. PubMed ID: 7637809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure of the mouse lysyl oxidase gene.
    Contente S; Csiszar K; Kenyon K; Friedman RM
    Genomics; 1993 May; 16(2):395-400. PubMed ID: 8100214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.
    Tanaka N; Ishihara M; Kitagawa M; Harada H; Kimura T; Matsuyama T; Lamphier MS; Aizawa S; Mak TW; Taniguchi T
    Cell; 1994 Jun; 77(6):829-39. PubMed ID: 8004672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.
    Harada H; Kitagawa M; Tanaka N; Yamamoto H; Harada K; Ishihara M; Taniguchi T
    Science; 1993 Feb; 259(5097):971-4. PubMed ID: 8438157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversion and rereversion in ras-transformed cells.
    Marshall CJ
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract]   [Full Text] [Related]  

  • 46. Retinoic acid prevents downregulation of ras recision gene/lysyl oxidase early in adipocyte differentiation.
    Dimaculangan DD; Chawla A; Boak A; Kagan HM; Lazar MA
    Differentiation; 1994 Nov; 58(1):47-52. PubMed ID: 7867896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of lysyl oxidase from cDNA constructs in mammalian cells: the propeptide region is not essential to the folding and secretion of the functional enzyme.
    Kagan HM; Reddy VB; Panchenko MV; Nagan N; Boak AM; Gacheru SN; Thomas KM
    J Cell Biochem; 1995 Nov; 59(3):329-38. PubMed ID: 8567751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.
    Sato KY; Polakis PG; Haubruck H; Fasching CL; McCormick F; Stanbridge EJ
    Cancer Res; 1994 Jan; 54(2):552-9. PubMed ID: 8275494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis.
    Sommer P; Gleyzal C; Raccurt M; Delbourg M; Serrar M; Joazeiro P; Peyrol S; Kagan H; Trackman PC; Grimaud JA
    Lab Invest; 1993 Oct; 69(4):460-70. PubMed ID: 7901452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
    Mello ML; Contente S; Vidal BC; Planding W; Schenck U
    Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defining the mechanisms of transformation through analysis of revertant cells.
    Bassin RH; Benade LE
    Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
    [No Abstract]   [Full Text] [Related]  

  • 52. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.
    Harada H; Kondo T; Ogawa S; Tamura T; Kitagawa M; Tanaka N; Lamphier MS; Hirai H; Taniguchi T
    Oncogene; 1994 Nov; 9(11):3313-20. PubMed ID: 7936656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2.
    Park KC; Shimizu K; Hayakawa T; Tanaka N
    Br J Cancer; 1998 Jun; 77(12):2081-7. PubMed ID: 9649118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IRF regulation of HIV-1 long terminal repeat activity.
    Battistini A; Marsili G; Sgarbanti M; Ensoli B; Hiscott J
    J Interferon Cytokine Res; 2002 Jan; 22(1):27-37. PubMed ID: 11846973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of interferon regulatory factor 1 and 2 in hematopoietic cells of children with juvenile myelomonocytic leukemia.
    Mild GC; Schmahl GE; Shayan P; Niemeyer CM
    Leuk Lymphoma; 1999 Nov; 35(5-6):507-11. PubMed ID: 10609788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
    Müllauer L; Fujita H; Ishizaki A; Kuzumaki N
    Oncogene; 1993 Sep; 8(9):2531-6. PubMed ID: 8395682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Forced expression of YL-1 protein suppresses the anchorage-independent growth of Kirsten sarcoma virus-transformed NIH3T3 cells.
    Horikawa I; Tanaka H; Yuasa Y; Suzuki M; Shimizu M; Oshimura M
    Exp Cell Res; 1995 Sep; 220(1):11-7. PubMed ID: 7664828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon regulatory factor 1 induces the expression of the interferon-stimulated genes.
    Henderson YC; Chou M; Deisseroth AB
    Br J Haematol; 1997 Mar; 96(3):566-75. PubMed ID: 9054665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor suppression and potentiation by manipulation of pp32 expression.
    Bai J; Brody JR; Kadkol SS; Pasternack GR
    Oncogene; 2001 Apr; 20(17):2153-60. PubMed ID: 11360199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.
    Liu J; Guan X; Ma X
    J Biol Chem; 2005 Jul; 280(26):24347-55. PubMed ID: 15860458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.